anmelden
AstraZeneca Aktie
150,95
EUR
-1,40
EUR
-0,92
%
152,20
EUR
+0,65
EUR
+0,43
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
AstraZeneca Aktie Analyse
| 27.04.17 | AstraZeneca Neutral | UBS AG | |
| 24.04.17 | AstraZeneca overweight | Morgan Stanley | |
| 21.04.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 18.04.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 10.04.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.04.17 | AstraZeneca buy | Deutsche Bank AG | |
| 07.04.17 | AstraZeneca Reduce | HSBC | |
| 05.04.17 | AstraZeneca Neutral | UBS AG | |
|
Werbung
|
|||
| 29.03.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 23.03.17 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 20.03.17 | AstraZeneca buy | Deutsche Bank AG | |
| 20.03.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.03.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 15.03.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 15.03.17 | AstraZeneca buy | Deutsche Bank AG | |
| 09.03.17 | AstraZeneca buy | Jefferies & Company Inc. | |
| 08.03.17 | AstraZeneca overweight | Barclays Capital | |
| 28.02.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 21.02.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 17.02.17 | AstraZeneca buy | Jefferies & Company Inc. | |
| 17.02.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.02.17 | AstraZeneca Hold | HSBC | |
| 07.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 06.02.17 | AstraZeneca buy | Deutsche Bank AG | |
| 03.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.02.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 02.02.17 | AstraZeneca buy | UBS AG | |
| 30.01.17 | AstraZeneca buy | Jefferies & Company Inc. | |
| 26.01.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 24.01.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 23.01.17 | AstraZeneca buy | Deutsche Bank AG | |
| 19.01.17 | AstraZeneca buy | Deutsche Bank AG | |
| 18.01.17 | AstraZeneca overweight | Morgan Stanley | |
| 18.01.17 | AstraZeneca buy | Deutsche Bank AG | |
| 12.01.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.01.17 | AstraZeneca buy | UBS AG | |
| 04.01.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 23.12.16 | AstraZeneca buy | Kepler Cheuvreux | |
| 19.12.16 | AstraZeneca buy | Jefferies & Company Inc. | |
| 12.12.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.12.16 | AstraZeneca buy | Deutsche Bank AG | |
| 07.12.16 | AstraZeneca buy | Deutsche Bank AG | |
| 30.11.16 | AstraZeneca buy | Deutsche Bank AG | |
| 28.11.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 17.11.16 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.11.16 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 15.11.16 | AstraZeneca buy | Deutsche Bank AG | |
| 11.11.16 | AstraZeneca buy | Jefferies & Company Inc. | |
| 11.11.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
Werbung
Werbung